Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib
Status:
Completed
Trial end date:
2014-04-04
Target enrollment:
Participant gender:
Summary
This study is being conducted to measure the relative bioavailability of the original gelatin
capsule formulation and a new formulation, immediate release (IR) tablet of Afuresertib
(GSK2110183). The study will be composed of Screening, Treatment, and Follow-up Periods. A
subject's total time involved in the study will be approximately 9 weeks. The study will
enroll approximately 18 healthy volunteers.